| 81 |
|
A Phase I Study of Anti-Kinase Insert Domain-containing Receptor Antibody, IMC-1C11, in Patients with Liver Metastases from Colorectal Carcinoma/
|
Posey, J. A
|
The Association
|
2003
|
|
|
|
| 82 |
|
A PHASE I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma/
|
Duenas-Gonzalez, A
|
Pergamon Press
|
2003
|
|
|
|
| 83 |
|
A phase I study of combined therapy with radiation and escalating dose of weekly gemcitabine in patients with pancreatic carcinoma/
|
Oya, N
|
Pergamon Press
|
2003
|
|
|
|
| 84 |
|
A Phase I Study of Docetaxel Plus Cyclophosphamide in Solid Tumors followed by a Phase II Study as First-Line Therapy in Metastatic Breast Cancer/
|
Trent, J. C
|
The Association
|
2003
|
|
|
|
| 85 |
|
A Phase I Study of Gemcitabine with Concurrent Radiotherapy in Stage III, Locally Advanced Non-Small Cell Lung Cancer/
|
van Putten, J. W. G
|
The Association
|
2003
|
|
|
|
| 86 |
|
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer/
|
Martenson Jr, J. A
|
Pergamon Press
|
2003
|
|
|
|
| 87 |
|
A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer/
|
Gunawardana, D. H
|
The Association
|
2003
|
|
|
|
| 88 |
|
A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy/
|
Seddon, B. M
|
The Association
|
2003
|
|
|
|
| 89 |
|
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant/
|
Halperin, S. A
|
Butterworths
|
2003
|
|
|
|
| 90 |
|
A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer/
|
Lu, C
|
The Association
|
2003
|
|
|
|
| 91 |
|
A Phase I Trial of CD3/CD28-activated T Cells (Xcellerated T Cells) and Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma/
|
Thompson, J. A
|
The Association
|
2003
|
|
|
|
| 92 |
|
A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma/
|
Marcus, K. J
|
Pergamon Press
|
2003
|
|
|
|
| 93 |
|
A Phase I Trial of SD-9427 (Progenipoietin) with a Multi-peptide Vaccine for Resected Metastatic Melanoma/
|
Pullarkat, V
|
The Association
|
2003
|
|
|
|
| 94 |
|
A Phase I Trial of the Farnesyl Protein Transferase Inhibitor R115777 in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer/
|
Adjei, A. A
|
The Association
|
2003
|
|
|
|
| 95 |
|
A Phase I Trial of ZD9331, a Water-Soluble, Nonpolyglutamatable, Thymidylate Synthase Inhibitor/
|
Plummer, R
|
The Association
|
2003
|
|
|
|
| 96 |
|
A phase I trial using a parotid-sparing, accelerated Intensity-Modulated Radiotherapy (IMRT) regimen to treat locally advanced head and neck squamous cell carcinoma/
|
Lauve, A
|
Pergamon Press
|
2003
|
|
|
|
| 97 |
|
A pH-Dependent Aquomet-to-Hemichrome Transition in Crystalline Horse Methemoglobin/
|
Robinson, V. L
|
American Chemical Society
|
2003
|
|
|
|
| 98 |
|
A pH-dependent SERS study of thiophene-2-carboxylic acid adsorbed on Ag-sols
|
Sarkar, U. K
|
North Holland
|
2003
|
|
|
|
| 99 |
|
A phenolysis route to a new type of octanuclear iron(III) wheel: [Fe~8(OH)~4(OPh)~8(O~2CBu^t)~1~2]/
|
Canada-Vilalta, C
|
Royal Society of Chemistry
|
2003
|
|
|
|
| 100 |
|
A PHO80-like Cyclin and a B-type Cyclin Control the Cell Cycle of the Procyclic Form of Trypanosoma brucei
|
Li, Z.; Wang, C. C.
|
WAVERLY PRESS INC
|
2003
|
|
|
|
